Showing results (371-380 of 651) with videos related to
Sort By:
Pageof 66
PPAR Research|September 5, 2008
Omega-3 Fatty Acids and PPARgamma in CancerIris J Edwards, Joseph T O'FlahertyPPAR Research|September 24, 2008
Rosiglitazone Suppresses the Growth and Invasiveness of SGC-7901 Gastric Cancer Cells and Angiogenesis In Vitro via PPARgamma Dependent and Independent MechanismsQing He, Ruiping Pang, Xin Song, et al.PPAR Research|August 2, 2008
Role of peroxisome proliferator-activated receptor alpha in the control of cyclooxygenase 2 and vascular endothelial growth factor: involvement in tumor growthRaquel Grau, Manuel D Díaz-Muñoz, Cristina Cacheiro-Llaguno, et al.PPAR Research|August 2, 2008
Rosiglitazone inhibits adrenocortical cancer cell proliferation by interfering with the IGF-IR intracellular signalingGiulia Cantini, Adriana Lombardi, Elisabetta Piscitelli, et al.PPAR Research|August 16, 2008
Activated PPARgamma Targets Surface and Intracellular Signals That Inhibit the Proliferation of Lung Carcinoma CellsShou Wei Han, Jesse RomanPPAR Research|July 23, 2008
PPAR Alpha Regulation of the Immune Response and Autoimmune EncephalomyelitisYuhong Yang, Anne R Gocke, Amy Lovett-Racke, et al.PPAR Research|June 21, 2008
Structural Development Studies of Subtype-Selective Ligands for Peroxisome Proliferator-Activated Receptors (PPARs) Based on the 3,4-Disubstituted Phenylpropanoic Acid Scaffold as a Versatile TemplateHiroyuki Miyachi, Yuichi HashimotoPPAR Research|November 8, 2008
PPARdelta Agonism for the Treatment of Obesity and Associated Disorders: Challenges and OpportunitiesMylène Perreault, David V Erbe, James F TobinPPAR Research|August 25, 2020
PPARD May Play a Protective Role against the Development of SchizophreniaXinrong Li, Sha Liu, Karan Kapoor, et al.Pageof 66